Navigation Links
Contract Research Organization WCCT Global Announces Acquisition of Early Phase Ophthalmology and Aesthetics Capabilities
Date:9/11/2013

Costa Mesa, California (PRWEB) September 11, 2013

WCCT Global, a contract research organization headquartered in Orange County, California, announced today the acquisition of OC Clinical Trials and Consulting, an early stage ophthalmology and cosmetology research practice. This acquisition provides WCCT Global with expanded early phase capabilities in its Ophthalmology Center of Excellence in the areas of Cornea & External Disease, Uveitis, Vitreoretinal Diseases, Glaucoma, Neuro-ophthlamology, Oculoplastics and pediatric ophthalmic conditions such as Strabismus and Amblyopia. Dr. Michael A. Sheety, WCCTG’s Medical and Surgery Director of Ophthalmology and Aesthetics says, “We are very excited to integrate this exceptional group of 6 Investigators and 5 study coordinators and research personnel into WCCT Global’s organization. The team brings more than 75 combined years of clinical and research experience in the areas of ophthalmology and aesthetics, and we’re confident that by joining this experience with WCCT’s solid infrastructure and reputation for conducting quality clinical trials, we will be able to provide unique capabilities in the area of ophthalmology and aesthetics to our Sponsors.” Dr. Sheety is board certified and fellowship trained in all aspects of refractive eye care including suture-less surgery and corneal transplantation. He has performed thousands of vision correction procedures, and also has extensive experience performing reconstructive and cosmetic eyelid surgery. In addition to his role overseeing WCCT Global’s Ophthalmology Research Center of Excellence, Dr. Sheety also serves as the chief consultant at the Children’s Hospital of Orange Country for all reconstructive eyelid injuries and the Grossman Burn Center at Western Medical Center in Santa Ana, CA. In addition, Dr. Sheety owns and operates one of the leading facilities in the treatment and prevention of dry eye disease. His dry eye facility conducts specialized treatments such as laboratory micro-analysis of tears and autologus growth-factor drops compounded for each patient to meet their exact needs.

With this acquisition, WCCT now owns and operates five total sites, including two Clinical Pharmacology Units (CPUs) with 180+ beds. WCCT’s ophthalmic patient database has grown 10-fold with patients of varying ages and demographics. Additionally, with an ophthalmology and optometry referral network of >20 facilities in southern California, WCCT now has direct access to more than 40,000 ophthalmology and optometry patients. In the cosmetology and aesthetics space, WCCT’s network has grown to >45 physicians throughout southern California. WCCT’s CEO, Dr. Kenneth T. Kim says, “WCCT is thrilled to have added Dr. Michael Sheety and the rest of the OC Clinical Trials research staff to the WCCT team. As the trend toward incorporation of patient populations earlier into clinical trials intensifies, WCCT is continuously looking to further expand our capabilities in patient populations. We want to provide Sponsors with the ability to run trials in Phase I and beyond in the ophthalmology therapeutic area, bridge quickly into patient populations in a proof of concept design, and then carry on into the larger, later stage patient efficacy trials in the blink of an eye.”

About WCCT Global:
WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, "With compassion for people, we strive for tomorrow’s therapies to be available today" truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you are interested in how WCCT Global can service one of your upcoming clinical studies, CLICK HERE.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11111241.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Florida Contracts L-A-B for Environmental Laboratory Assessment Services
2. Contract Research Organization WCCT Global Welcomes Lada Smirnova to the Executive Team as Chief Financial Officer
3. The Construction Audit and Cost Control Institute to Address "The Benefits of Auditing Construction Contracts and Contractors"
4. Study examines relationship of a commercial ACO contract with medical spending
5. Employment Lawyers at Gilman Law LLP Investigate Independent Contractor Misclassification in the State of Massachusetts Following the Recent Fedex Decision
6. Ben Davies, Chief Financial Officer at Octo Consulting Group was Announced Washington Business Journal (WBJ) 2013 Government Contracting CFO of the Year Award
7. Human Capital Resource, LLC, Adds Contract Staffing to Its Recruiting Services
8. BigToys Awarded Prestigious FAC79 Statewide Contract for Massachusetts
9. How Hiring a Painting Contractor in Michigan Can Save Homeowners Money
10. Specialty Drug Delivery Firm Integral BioSystems LLC to Participate in Contract Pharma Magazine’s 12th Annual Contracting & Outsourcing Conference & Tabletop Exhibition
11. Michael Melville of IntelliSoft Group Joins Partner Firm, Contract Logix, as Group CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the leading ... with Tennessee Counseling Association. This new relationship allows TherapySites to continue ... Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited about ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, ... the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where ... city’s history as home to some of the world’s leading providers of cereal and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: